ITOS - ITeos Therapeutics Inc
10.15
0.020 0.197%
Share volume: 11,006,826
Last Updated: 08-28-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.13
0.02
0.00%
Summary score
34%
Profitability
36%
Dept financing
22%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.61%
Return on assets
-0.72%
Return on sales
-4.01%
Return on invested capital
-8.98%
Total debt ratio
18.71%
Debt ratio change over timeo
-2.55%
Current Ratio
12.91%
Quick Ratio
12.13%
Cash Position Ratio
9.52%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-5.33%
Return on sales
-40.47%
Return on invested capital
0%
Total debt ratio
13.22%
Debt ratio change over timeo
0%
Current Ratio
14.91%
Quick Ratio
0%
Cash Position Ratio
4.56%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-6.14%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
14.49%
Debt ratio change over time
0%
Current Ratio
14.13%
Quick Ratio
0%
Cash Position Ratio
4.12%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-145.59%
Return on assets
-125.84%
Return on sales
-494.43%
Return on invested capital
-186.12%
Total debt ratio
-254.55%
Debt ratio change over time
-2.55%
Current Ratio
-133.13%
Quick Ratio
-142.05%
Cash Position Ratio
-128.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ITOS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 3.61% | 18.97% | 6.3% | 4.9% |
| Return on assets | -0.72% | 3.05% | 3.04% | 2.27% |
| Return on sales | -4.01% | 29.08% | 27.81% | 22.73% |
| Return on invested capital | -8.98% | 5.17% | 3.5% | 4.81% |
| Profitability | 5% | 100% | 74% | 68% |
| Total debt ratio | 18.71% | 92.73% | 66.91% | 46.96% |
| Debt ratio change over time | -2.55% | 21.88% | 144.36% | 14.72% |
| Dept financing | 5% | 29% | 43% | 15% |
| Current Ratio | 14.91% | 1.25% | 1.34% | 1.58% |
| Quick Ratio | 0% | 0.92% | 1.18% | 1.05% |
| Cash Position Ratio | 4.56% | 0.44% | 0.54% | 0.46% |
| Liquididy | 75% | 8% | 6% | 9% |
| Short-term ratios | ITOS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -5.33% | 2.68% | 3.48% | 1.89% |
| Return on sales | -40.47% | 21.68% | 28.93% | 21.33% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 32% |
| Total debt ratio | 13.22% | 92.96% | 66.32% | 40.7% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 29% | 25% | 18% | 11% |
| Current Ratio | 14.91% | 1.25% | 1.34% | 1.58% |
| Quick Ratio | 0% | 0.92% | 1.18% | 1.05% |
| Cash Position Ratio | 4.56% | 0.44% | 0.54% | 0.46% |
| Liquididy | 50% | 24% | 30% | 27% |